DE69737889D1 - Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen. - Google Patents

Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen.

Info

Publication number
DE69737889D1
DE69737889D1 DE69737889T DE69737889T DE69737889D1 DE 69737889 D1 DE69737889 D1 DE 69737889D1 DE 69737889 T DE69737889 T DE 69737889T DE 69737889 T DE69737889 T DE 69737889T DE 69737889 D1 DE69737889 D1 DE 69737889D1
Authority
DE
Germany
Prior art keywords
calcium
low
potassium channel
activated potassium
activated column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737889T
Other languages
English (en)
Other versions
DE69737889T2 (de
Inventor
John P Adelman
James Maylie
Chris T Bond
Christopher P Silvia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICA GEN Inc
Oregon Health Science University
Original Assignee
ICA GEN Inc
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICA GEN Inc, Oregon Health Science University filed Critical ICA GEN Inc
Application granted granted Critical
Publication of DE69737889D1 publication Critical patent/DE69737889D1/de
Publication of DE69737889T2 publication Critical patent/DE69737889T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
DE69737889T 1996-09-11 1997-09-10 Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen. Expired - Lifetime DE69737889T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2645196P 1996-09-11 1996-09-11
US26451P 1996-09-11
US4005297P 1997-03-07 1997-03-07
US40052P 1997-03-07
US4523397P 1997-04-17 1997-04-17
US45233P 1997-04-17
PCT/US1997/016033 WO1998011139A1 (en) 1996-09-11 1997-09-10 Small and intermediate conductance, calcium-activated potassium channels and uses thereof

Publications (2)

Publication Number Publication Date
DE69737889D1 true DE69737889D1 (de) 2007-08-16
DE69737889T2 DE69737889T2 (de) 2008-03-13

Family

ID=27362774

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69739956T Expired - Lifetime DE69739956D1 (de) 1996-09-11 1997-09-10 Calciumaktivierter Kaliumkanal mit zwischenzeitlicher Konduktanz und Verwendungen davon
DE69737889T Expired - Lifetime DE69737889T2 (de) 1996-09-11 1997-09-10 Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69739956T Expired - Lifetime DE69739956D1 (de) 1996-09-11 1997-09-10 Calciumaktivierter Kaliumkanal mit zwischenzeitlicher Konduktanz und Verwendungen davon

Country Status (8)

Country Link
US (9) US6797486B2 (de)
EP (1) EP0948542B1 (de)
JP (5) JP4052525B2 (de)
AT (1) ATE366260T1 (de)
AU (1) AU726158B2 (de)
CA (1) CA2265485C (de)
DE (2) DE69739956D1 (de)
WO (1) WO1998011139A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8348498A (en) * 1997-07-15 1999-02-10 Zeneca Limited Methods
CA2297103A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
AU2001265384A1 (en) 2000-06-06 2001-12-17 Millennium Pharmaceuticals, Inc. 52906, 33408, and 12189, potassium channel family members and uses thereof
WO2002053171A2 (de) * 2000-12-28 2002-07-11 Switch Biotech Aktiengesellschaft Verwendung von 'intermediate-conductance kaliumkanälen und modulatoren zur diagnose und behandlung von krankheiten mit gestörter keratinozytenaktivität
US7022480B1 (en) * 2001-10-11 2006-04-04 The Regents Of The University Of California Exons of the hSKCa3/KCNN3 gene
US20050250090A1 (en) * 2003-10-28 2005-11-10 Edward Kaftan Assay systems and methods for detecting molecules that interact with SK2 channels
EP1884774A1 (de) * 2006-08-03 2008-02-06 INSERM (Institut National de la Santé et de la Recherche Medicale) Verfahren für In-vitro-Screening von Antikrebsverbindungen als Hemmer der SK3-Aktivität und derartige Antikrebsverbindungen
CN110378549B (zh) * 2019-05-31 2023-05-23 广东工业大学 一种基于fahp-熵权法的输电杆塔鸟害等级评估方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392957B (de) 1987-08-06 1991-07-25 Technoagrar Consulting Ag Verfahren zur behandlung und entsorgung von gemengen aus feststoffen und fluessigkeiten
US6307030B1 (en) * 1988-04-15 2001-10-23 The University Of North Carolina At Chapel Hill Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
CA2116280A1 (en) 1993-03-05 1994-09-06 Marcy E. Macdonald Huntingtin dna, protein and uses thereof
US5519003A (en) 1994-02-01 1996-05-21 Board Of Trustees Of The Leland Stanford Junior University WD-40-derived peptides and uses thereof
US6277978B1 (en) * 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
AU8348498A (en) 1997-07-15 1999-02-10 Zeneca Limited Methods
CA2297103A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
WO1999025347A2 (en) 1997-11-14 1999-05-27 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction

Also Published As

Publication number Publication date
EP0948542B1 (de) 2007-07-04
JP2008092950A (ja) 2008-04-24
US6797486B2 (en) 2004-09-28
US6987169B2 (en) 2006-01-17
US6828123B2 (en) 2004-12-07
DE69739956D1 (de) 2010-09-16
US7026451B2 (en) 2006-04-11
JP4052525B2 (ja) 2008-02-27
ATE366260T1 (de) 2007-07-15
US20020192757A1 (en) 2002-12-19
US20030082684A1 (en) 2003-05-01
US6894147B2 (en) 2005-05-17
CA2265485A1 (en) 1998-03-19
US20030105284A1 (en) 2003-06-05
US20050214845A1 (en) 2005-09-29
US6828122B2 (en) 2004-12-07
US6692937B2 (en) 2004-02-17
AU4266097A (en) 1998-04-02
JP4052582B2 (ja) 2008-02-27
EP0948542A1 (de) 1999-10-13
JP2006320333A (ja) 2006-11-30
EP0948542A4 (de) 2004-04-14
US20030044910A1 (en) 2003-03-06
JP2004065264A (ja) 2004-03-04
JP2000514310A (ja) 2000-10-31
DE69737889T2 (de) 2008-03-13
US20020165379A1 (en) 2002-11-07
US20020155531A1 (en) 2002-10-24
US20030040048A1 (en) 2003-02-27
US7534869B2 (en) 2009-05-19
WO1998011139A1 (en) 1998-03-19
CA2265485C (en) 2006-08-01
US6828420B2 (en) 2004-12-07
AU726158B2 (en) 2000-11-02
JP2004024268A (ja) 2004-01-29
US20030082683A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
PT1015585E (pt) Homologos de ligandos de tie
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
ATE218708T1 (de) Elektrochemischer affinitätsassay
HK1152378A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
FR10C0025I1 (de)
ATE365916T1 (de) Biodetektoren für spezifische liganden
DE69811886D1 (de) Biosensor mit ionendurchlässige kanäle aufweisender lipidmembran
AU2001268449A1 (en) Toxicity typing using liver stem cells
EP1131333A4 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE273956T1 (de) Arylsubstituierte olefinische amine und ihre verwendung als cholinergische rezeptoragonisten
ID24876A (id) Senyawa-senyawa indola tersubstitusi-2,3 sebagai penghambat cox-2
DE69737889D1 (de) Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen.
EP1032837A4 (de) Zielsequenzen für synthetische moleküle und verfahren für deren verwendung
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
AU2002229633A1 (en) Electrophoresis device, electrophoresis method using an electrophoresis device and utilization of an electrophoresis device
DK1058738T3 (da) Fremgangsmåde til screening, baseret på fluorescens-polarisering
DE69920487D1 (de) Tau als marker für frühe schäden des zentralen nervensystems
AU4429401A (en) Improved device for sample analysis by multiple capillary electrophoresis with solid/solid thermal control
IS2530B (is) Aðferð til að greina prótín-prótín víxlverkun
DK1242816T3 (da) Kromatografimateriale og fremgangsmåder ved anvendelse af dette
TR199900430T2 (xx) �kameli 1,2,3,4-tetrahidro-2-dibenzofuranaminler ve 2-aminosiklohepta$b] benzofuranlar.
EA199900893A1 (ru) Бактериальные плазмиды
EP1892252A3 (de) Calciumaktivierter Kaliumkanal mit zwischenzeitlicher Konduktanz und Verwendungen davon
EE200100234A (et) PRV-1-geen ja selle kasutamine
DK199900148A (da) Enzym samt DNA-sekvens, der koder for dette

Legal Events

Date Code Title Description
8364 No opposition during term of opposition